Trial intelligence / Profile preview

Codonopsis Pilosula for Cancer-Related Fatigue in Pancreatic Cancer

NCT05613465Unknown

Sponsor
Zhejiang Provincial People's Hospital
Start
Oct 2022
Primary completion
Oct 2024
Modality
Classical Binding Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of codonopsis pilosula in cancer-related fatigue (CRF) (2 arms), sponsored by Zhejiang Provincial People's Hospital. Primary endpoint: Cancer-related fatigue at 9 weeks. Status: unknown.

02

Drugs

codonopsis pilosula
03

Conditions

cancer-related fatigue (CRF)

Beyond the preview

Go deeper on NCT05613465.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05613465.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call